Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $3.8B | $4B | $4B | $977.9M | $995.7M | |
| Gross Profit | $2.7B | $2.8B | $2.8B | $685.5M | $667.1M | |
| Operating Income | $595.9M | $679.5M | $631.5M | $162.4M | $156.1M | |
| EBITDA | $761.6M | $819.8M | $805M | $200.2M | $211.8M | |
| Diluted EPS | $4.71 | $5.87 | $5.16 | $1.55 | $0.78 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $2.5B | $2.5B | $2.7B | $2.6B | $2.5B | |
| Total Assets | $5.7B | $5.9B | $6.3B | $6.4B | $6.2B | |
| Current Liabilities | $1.8B | $1.8B | $2.1B | $2.1B | $2B | |
| Total Liabilities | $2.1B | $2.2B | $2.5B | $2.4B | $2.3B | |
| Total Equity | $3.5B | $3.7B | $3.8B | $3.9B | $4B | |
| Total Debt | $96.5M | $96.7M | $98.5M | $96.4M | $87.3M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $883.6M | $499.1M | $656.1M | $263.7M | $188.7M | |
| Cash From Investing | -$238.4M | -$214.3M | -$130.4M | -$8.9M | -$19.8M | |
| Cash From Financing | -$448.2M | -$503M | -$570.2M | $10.6M | -$64.1M | |
| Free Cash Flow | $686.1M | $373M | $566.6M | $233.9M | $169M | |
Align Technology, Inc. is a medical device company, which engages in the design, manufacture, and market of orthodontics, restorative, and aesthetic dentistry products. It operates through the Clear Aligner and Systems and Services segments. The Clear Aligner segment consists of invisalign full, teen, and assist products, and Vivera retainers for treating malocclusion. The Systems and Services segment includes sales related to iTero intraoral scanning systems, which includes a single hardware platform and restorative or orthodontic software options, upgrades and leases of scanner systems, sales of pre-owned scanner systems, subscription software, disposables, pay per scan services, as well as exocad’s CAD/CAM software solutions that integrate workflows to dental labs and dental practices. The company was founded by Zia Chishti, Brian Freyburger, and Kelsey Wirth in March 1997 and is headquartered in Tempe, AZ.
In the current month, ALGN has received 7 Buy ratings 8 Hold ratings, and 0 Sell ratings. The ALGN average analyst price target in the past 3 months is $179.80.
According to analysts, the consensus estimate is that Align Technology, Inc. share price will rise to $179.80 per share over the next 12 months.
Analysts are divided on their view about Align Technology, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Align Technology, Inc. is a Sell and believe this share price will drop from its current level to $150.00.
The price target for Align Technology, Inc. over the next 1-year time period is forecast to be $179.80 according to 15 Wall Street analysts, 7 of them rate the stock a Buy, 0 rate the stock a Sell, and 8 analysts rate the stock a Hold.
According to Wall Street analysts, the consensus rating for Align Technology, Inc. is a Hold. 8 of 15 analysts rate the stock a Hold at this time.
You can purchase shares of Align Technology, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Align Technology, Inc. shares.
Align Technology, Inc. was last trading at $167.61 per share. This represents the most recent stock quote for Align Technology, Inc.. Yesterday, Align Technology, Inc. closed at $160.13 per share.
In order to purchase Align Technology, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Signup to receive the latest stock alerts
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $3.9T
P/E Ratio: 36x
Market Cap: $3.8T
P/E Ratio: 39x
Regencell Bioscience Holdings Ltd. [RGC] is up 22.74% over the past day.
Innodata, Inc. [INOD] is up 4.84% over the past day.
AeroVironment, Inc. [AVAV] is up 6.62% over the past day.